Perrigo (PRGO) reported $1.04 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 3.5%. EPS of $0.60 for the same period compares to $0.29 a year ago.
The reported revenue represents a surprise of -3.59% over the Zacks Consensus Estimate of $1.08 billion. With the consensus EPS estimate being $0.56, the EPS surprise was +7.14%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Perrigo performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Sales- Consumer Self-Care Americas (CSCA): $620.70 million compared to the $656.74 million average estimate based on three analysts. The reported number represents a change of -3.6% year over year.
- Net Sales- Consumer Self-Care International (CSCI): $423.10 million versus the three-analyst average estimate of $431.57 million. The reported number represents a year-over-year change of -3.4%.
- Net Sales- CSCA- Oral care: $62 million versus $64.04 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -4.2% change.
- Net Sales- CSCA- Nutrition: $104.80 million versus the two-analyst average estimate of $111.86 million. The reported number represents a year-over-year change of +15.7%.
- Net Sales- CSCA- Healthy Lifestyle: $70.40 million compared to the $70.59 million average estimate based on two analysts. The reported number represents a change of -1.3% year over year.
- Net Sales- CSCA- Upper Respiratory: $137.90 million versus $133.24 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5.8% change.
- Gross Profit- Consumer Self-Care International- Adjusted (CSCI): $217.70 million versus the three-analyst average estimate of $219.76 million.
- Gross Profit- Consumer Self-Care Americas- Adjusted (CSCA): $210 million compared to the $196.22 million average estimate based on three analysts.
View all Key Company Metrics for Perrigo here>>>
Shares of Perrigo have returned +0.5% over the past month versus the Zacks S&P 500 composite's +10.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Perrigo Company plc (PRGO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
